» Articles » PMID: 37920935

Aza-BODIPY with Two Efficacious Fragments for NIR Light-driven Photothermal Therapy by Triggering Cancer Cell Apoptosis

Overview
Journal J Mater Chem B
Date 2023 Nov 3
PMID 37920935
Authors
Affiliations
Soon will be listed here.
Abstract

The reasonable structure of aza-BODIPY renders it as an efficient photothermal reagent for photothermal therapy. Herein, we describe the design and synthesis of aza-BODIPY NMeBu with the free rotating -butyl group and the dimethylamino-substituted segment to promote the photothermal conversion the excited state non-radiative transition. NMeBu was found to be the π-π stacking form in the unit cell based on X-ray analysis. NMeBu-NPs by self-assembly possessed a near-infrared absorption ( = 772 nm), and once activated by near-infrared light, the photothermal efficiency in aqueous solution can reach 49.3%. NMeBu-NPs can penetrate the cell and trigger cell death the apoptosis pathway under low concentration and low light power irradiation, thereby avoiding dark toxicity. Aza-BODIPY created using this procedure has excellent photothermal efficiency and could serve as a potential candidate for the treatment of cancer cells and tumors.